Therapeutic use of mini-scleral lenses in a patient with Graves’ ophthalmopathy

Sokol, 2010, Ocular surface effects of thyroid disease, Ocul Surf, 8, 29, 10.1016/S1542-0124(12)70215-X Gurdal, 2011, Ocular surface and dry eye in Graves’ disease, Curr Eye Res, 36, 8, 10.3109/02713683.2010.526285 Garrity, 2006, Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment, Am J Ophthalmol, 142, 147, 10.1016/j.ajo.2006.02.047 Versura, 2010, The ocular surface in thyroid diseases, Curr Opin Allergy Clin Immunol, 10, 486, 10.1097/ACI.0b013e32833e1749 Pullum, 2005, Scleral contact lenses: the expanding role, Cornea, 24, 269, 10.1097/01.ico.0000148311.94180.6b Cotter, 1998, Scleral contact lenses, J Am Optom Assoc, 69, 33 Jacobs, 2006, Updated on scleral lenses, Curr Opin Ophthalmol, 19, 298, 10.1097/ICU.0b013e328302cc4f Patel, 2002, Ocular manifestations of autoimmune disease, Am Fam Physician, 66, 991 Pullum, 2007, Therapeutic and ocular surface indications for scleral contact lenses, Ocul Surf, 5, 40, 10.1016/S1542-0124(12)70051-4 Schornack, 2010, Scleral lenses in the management of keratoconus, Eye Contact Lens, 36, 39, 10.1097/ICL.0b013e3181c786a6 Segal, 2003, Scleral contact lenses may help where other modalities fail, Cornea, 22, 308, 10.1097/00003226-200305000-00006 Ye, 2007, Role of mini-scleral gas-permeable in the treatment of corneal disorders, Eye Contact Lens, 33, 111, 10.1097/01.ICL.0000258593.20221.c6 Tappin, 2001, Scleral contact lenses for overnight wear in the management of ocular surface disorders, Eye, 15, 168, 10.1038/eye.2001.54